TAVECCHIO, SIMONA
TAVECCHIO, SIMONA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?
2024 S. Ferrucci, S. Tavecchio, A. Ceresa, L. Angileri, E. Berti, A. Marzano, M. Buoli
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?
2024 S. Ferrucci, S. Tavecchio, G. Nicolini, L. Angileri, A. Ceresa, G. Del Tordello, E. Berti, A. Marzano, M. Buoli
Emerging Systemic Treatments for Atopic Dermatitis
2023 S.M. Ferrucci, S. Tavecchio, A.V. Marzano, S. Buffon
Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
2023 S. Ferrucci, G. Casazza, M. Zussino, S. Tavecchio, A.V. Marzano, M. Tedeschi
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease
2022 S. Ferrucci, L. Angileri, S. Tavecchio, S. Fumagalli, A. Iurlo, D. Cattaneo, A.V. Marzano, C.A. Maronese
Topical tacrolimus during systemic therapy for severe atopic dermatitis in the clinical practice
2022 S.M. Ferrucci, L. Angileri, A.V. Marzano, E. Berti, S. Tavecchio
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
2021 S. Ferrucci, S. Tavecchio, L. Angileri, T. Surace, E. Berti, M. Buoli
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study
2021 A. Campanati, T. Bianchelli, R. Gesuita, C. Foti, G. Malara, G. Micali, P. Amerio, F. Rongioletti, M. Corazza, A. Patrizi, K. Peris, N. Pimpinelli, A. Parodi, M.C. Fargnoli, S.P. Cannavo, P. Pigatto, G. Pellacani, S.M. Ferrucci, G. Argenziano, F. Cusano, G. Fabbrocini, L. Stingeni, M.C. Potenza, M. Romanelli, L. Bianchi, A. Offidani, P. Romita, M.L. Musumeci, V. Piras, A. Borghi, C. Loi, N. Gori, F. Prigano, R. Gallo, M. Esposito, A. Campitello, L. Bolzano, S. Tavecchio, G. Calabrese, L. Di Costanzo, K. Hansel, N. Skroza, E. Tolino, G. Tonini, M. Talamonti
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
2021 S. Ferrucci, M. Romagnuolo, C.A. Maronese, F. Germiniasi, S. Tavecchio, L. Angileri, G. Casazza, A.V. Marzano, G. Genovese
Clinical and immunopathological features of idiopathic cutaneous IgM/IgG vasculitis versus idiopathic skin-limited IgA vasculitis
2021 A.V. Marzano, G. Genovese, S. Tavecchio, F. Germiniasi, D. Fanoni, M. Caproni, A. Ortega-Loayza
Transitory dissemination of molluscum contagiosum in a patient treated with dupilumab for atopic dermatitis
2020 S. Ferrucci, S. Tavecchio, S. Veraldi, E. Berti, V. Benzecry
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis : One-Year Experience of 221 Patients
2020 S. Tavecchio, L. Angileri, F. Pozzo Giuffrida, F. Germiniasi, A.V. Marzano, S. Ferrucci
Safety of dupilumab in severe atopic dermatitis and infection of Covid-19 : two case reports
2020 S. Ferrucci, M. Romagnuolo, L. Angileri, E. Berti, S. Tavecchio
Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab
2020 S.M. Ferrucci, S. Tavecchio, E.M. Favale, L. Angileri, D. Riva, M. Romagnuolo, A.E. Beretta, A.V. Marzano
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab : A Single-Center Real-Life Experience
2020 S. Ferrucci, G. Casazza, L. Angileri, S. Tavecchio, F.S. Germiniasi, E. Berti, A.V. Marzano, G. Genovese
Skin Involvement
2020 A.V. Marzano, S. Tavecchio, E. Berti
Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up
2020 M. Romagnuolo, L. Angileri, S. Tavecchio, A.V. Marzano, S. Ferrucci
Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab
2020 S. Ferrucci, S. Tavecchio, E. Berti, L. Angileri
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study
2019 F. Guicciardi, L. Atzori, A.V. Marzano, S. Tavecchio, G. Girolomoni, C. Colato, A.P. Villani, J. Kanitakis, C. Mitteldorf, R. Satta, B. Cribier, L. Gusdorf, M.T. Rossi, P. Calzavara-Pinton, I. Bielsa, M.T. Fernandez-Figueras, W. Kempf, G. Filosa, L. Pilloni, F. Rongioletti
What Italians think about acne: results of a survey on 2.327 patients and 2.327 mothers
2019 S. Tavecchio, M. Barbareschi, S. Veraldi